# Pyxis Oncology (PYXS) — Earnings

PYXS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/pyxs/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$0.35 |
| EPS estimate | −$0.33 |
| EPS surprise | −4.79% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Nov 3, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1782223/000119312525261696/pyxs-20250930.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 3, 2025 | −$0.33 | −$0.35 | -4.79% | — | — |
| Q2 2025 | Aug 14, 2025 | −$0.35 | −$0.30 | 14.70% | — | $2.8M |
| Q1 2025 | May 15, 2025 | −$0.29 | −$0.35 | -19.05% | — | — |
| Q4 2024 | Mar 18, 2025 | −$0.32 | −$0.62 | -93.63% | — | — |
| Q3 2024 | Nov 12, 2024 | −$0.32 | −$0.35 | -9.92% | — | — |
| Q2 2024 | Aug 14, 2024 | −$0.34 | −$0.29 | 14.28% | — | — |
| Q1 2024 | May 14, 2024 | −$0.24 | −$0.06 | 74.85% | $4.1M | $16.1M |
| Q4 2023 | Mar 21, 2024 | −$0.47 | −$0.34 | 28.41% | $200,000.00 | — |
| Q3 2023 | Nov 7, 2023 | −$0.51 | −$0.56 | -10.48% | — | — |
| Q2 2023 | Aug 11, 2023 | −$0.65 | −$0.41 | 36.60% | $625,000.00 | — |
| Q1 2023 | May 11, 2023 | −$0.90 | −$0.54 | 39.95% | — | — |
| Q4 2022 | Mar 22, 2023 | −$0.93 | −$1.04 | -11.79% | — | — |
| Q3 2022 | Nov 1, 2022 | −$0.81 | −$0.85 | -4.49% | — | — |
| Q2 2022 | Aug 15, 2022 | −$0.76 | −$0.79 | -3.66% | — | — |
| Q1 2022 | May 13, 2022 | −$0.61 | −$0.97 | -59.09% | — | — |
| Q4 2021 | Mar 29, 2022 | −$0.37 | −$0.53 | -43.68% | — | — |
| Q3 2021 | Nov 15, 2021 | −$0.53 | −$8.96 | -1605.69% | — | — |

## Frequently Asked Questions

### When did Pyxis Oncology (PYXS) last report earnings?

Pyxis Oncology last reported on Nov 3, 2025, covering fiscal Q3 2025.

### Did PYXS beat earnings estimates?

No. Pyxis Oncology reported EPS of −$0.35 for Q3 2025 against a −$0.33 estimate — a 4.79% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).